These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 35822409)
1. SPP1 as a key gene in the lymph node metastasis and a potential predictor of poor prognosis in head and neck carcinoma. Feng S; Yuan W; Sun Z; Guo X; Ling J; Chang A; Zhao H; Zhuo X J Oral Pathol Med; 2022 Aug; 51(7):620-629. PubMed ID: 35822409 [TBL] [Abstract][Full Text] [Related]
2. Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer. Brennan K; Espín-Pérez A; Chang S; Bedi N; Saumyaa S; Shin JH; Plevritis SK; Gevaert O; Sunwoo JB; Gentles AJ Genome Med; 2023 Nov; 15(1):98. PubMed ID: 37978395 [TBL] [Abstract][Full Text] [Related]
3. The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer, SNAI1, in head and neck carcinoma. Zhao H; Ling J; Huang Y; Chang A; Zhuo X J Oral Pathol Med; 2021 Feb; 50(2):145-154. PubMed ID: 32945534 [TBL] [Abstract][Full Text] [Related]
4. TBC1D14 inhibits autophagy to suppress lymph node metastasis in head and neck squamous cell carcinoma by downregulating macrophage erythroblast attacher. Lu T; Li Y; Pan M; Yu D; Wang Z; Liu C; Hu G Int J Biol Sci; 2022; 18(5):1795-1812. PubMed ID: 35342354 [No Abstract] [Full Text] [Related]
5. The role of SPP1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma. Cai X; Zhang H; Li T Int J Oral Maxillofac Surg; 2022 Jun; 51(6):732-741. PubMed ID: 34489157 [TBL] [Abstract][Full Text] [Related]
7. SPP1 is associated with adverse prognosis and predicts immunotherapy efficacy in penile cancer. Zou Y; Tan X; Yuan G; Tang Y; Wang Y; Yang C; Luo S; Wu Z; Yao K Hum Genomics; 2023 Dec; 17(1):116. PubMed ID: 38111044 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer. Liu K; Hu H; Jiang H; Liu C; Zhang H; Gong S; Wei D; Yu Z Mol Carcinog; 2020 Oct; 59(10):1147-1158. PubMed ID: 32805066 [TBL] [Abstract][Full Text] [Related]
9. IGFBP3 as an indicator of lymph node metastasis and unfavorable prognosis for papillary thyroid carcinoma. Huang Y; Chang A; Zhou W; Zhao H; Zhuo X Clin Exp Med; 2020 Nov; 20(4):515-525. PubMed ID: 32596748 [TBL] [Abstract][Full Text] [Related]
10. Macrophage-Related SPP1 as a Potential Biomarker for Early Lymph Node Metastasis in Lung Adenocarcinoma. Dong B; Wu C; Huang L; Qi Y Front Cell Dev Biol; 2021; 9():739358. PubMed ID: 34646827 [TBL] [Abstract][Full Text] [Related]
11. Inhibitor of DNA Binding 2 (ID2): A Novel Marker for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. Kim HR; Moon JH; Lee JH; Lim YC Ann Surg Oncol; 2021 Oct; 28(11):6479-6488. PubMed ID: 33783641 [TBL] [Abstract][Full Text] [Related]
12. Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer. Bie T; Zhang X J Immunol Res; 2021; 2021():8569575. PubMed ID: 34977258 [TBL] [Abstract][Full Text] [Related]
13. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer. Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801 [TBL] [Abstract][Full Text] [Related]
15. The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma. Zhang Y; Chen M; Liu Z; Wang X; Ji T BMC Cancer; 2021 Nov; 21(1):1254. PubMed ID: 34800986 [TBL] [Abstract][Full Text] [Related]
16. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis. Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894 [TBL] [Abstract][Full Text] [Related]
17. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis. Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087 [TBL] [Abstract][Full Text] [Related]
18. Identification of immune-related genes in the prognosis of head and neck cancer using a novel prognostic signature model. Chang A; Wang Y; Guo X; Sun Z; Ling J; Pan J; Zhuo X Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Oct; 136(4):478-489. PubMed ID: 37620228 [TBL] [Abstract][Full Text] [Related]
19. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer. Yang C; Cao F; Huang S; Zheng Y Front Immunol; 2021; 12():717505. PubMed ID: 34335633 [TBL] [Abstract][Full Text] [Related]
20. CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance. Sun WH; Peng TJ; Tang SJ; Lin JY; Wang CY; Fang HJ; Sun KH J Oral Pathol Med; 2022 Oct; 51(9):791-800. PubMed ID: 35998229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]